Success rate at 2 years for discogenic low back pain surgeries was 85% for patients whose treatment strategy was consistent with...
Marks the eighth advisor to growing KOL program to build strong body of clinical evidence and support US commercialization Aclarion to...
NociscanTM is the first evidence-supported SaaS platform to objectively measure discogenic biomarkers for insight into pathological pain...
Director of Endoscopic Spine Surgery at the University of Miami Broomfield, CO, Jan. 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Aclarion...
Broomfield, CO, Jan. 17, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Aclarion, Inc. (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a...
Broomfield, CO, Dec. 22, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a...
Development of this program supports Aclarion’s commitment to lead with strong clinical evidence and engage the payer community through key...
Dr. Uribe is the fourth national KOL to join the Aclarion team this year. Development of this program supports Aclarion’s commitment to lead...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.